Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Tau PET Imaging in Atypical Dementias

Trial Profile

Tau PET Imaging in Atypical Dementias

Phase of Trial: Phase I

Latest Information Update: 10 Jun 2018

At a glance

  • Drugs Flortaucipir-F-18 (Primary)
  • Indications Primary progressive aphasia
  • Focus Diagnostic use
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 03 Apr 2018 Planned End Date changed from 1 Nov 2022 to 1 Feb 2023.
    • 03 Apr 2018 Planned primary completion date changed from 1 Feb 2018 to 1 Feb 2022.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top